{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:19:15Z","timestamp":1788092355616,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12028-020-00986-4","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T18:04:11Z","timestamp":1589997851000},"page":"102-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Amantadine and Modafinil as Neurostimulants Following Acute Stroke: A Retrospective Study of Intensive Care Unit Patients"],"prefix":"10.1007","volume":"34","author":[{"given":"Angela M.","family":"Leclerc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Riker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Nocella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Eldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"key":"986_CR1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139:e56\u2013528.","journal-title":"Circulation"},{"key":"986_CR2","first-page":"421","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","unstructured":"Centers for Disease Control and Prevention (CDC). Prevalence and most common causes of disability among adults\u2014United States, 2005. MMWR Morb Mortal Wkly Rep. 2009;58:421\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"986_CR3","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1161\/STROKEAHA.118.020376","volume":"50","author":"KI Gallacher","year":"2019","unstructured":"Gallacher KI, Jani BD, Hanlon P, Nicholl BI, Mair FS. Multimorbidity in stroke. Stroke. 2019;50:1919\u201326.","journal-title":"Stroke"},{"key":"986_CR4","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1161\/STROKEAHA.113.001196","volume":"44","author":"BG Vickrey","year":"2013","unstructured":"Vickrey BG, Brott TG, Koroshetz WJ, Stroke Research Priorities Meeting Steering Committee and the National Advisory Neurological Disorders and Stroke Council, National Institute of Neurological Disorders and Stroke. Research priority setting: a summary of the 2012 NINDS Stroke Planning Meeting Report. Stroke. 2013;44:2338\u201342.","journal-title":"Stroke"},{"key":"986_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/STROKEAHA.114.007434","volume":"46","author":"J Bernhardt","year":"2015","unstructured":"Bernhardt J, English C, Johnson L, Cumming TB. Early mobilization after stroke: early adoption but limited evidence. Stroke. 2015;46:1141\u20136.","journal-title":"Stroke"},{"key":"986_CR6","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1161\/STR.0000000000000098","volume":"47","author":"CJ Winstein","year":"2016","unstructured":"Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Quality of Care and Outcomes Research, et al. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2016;47:e98\u2013169.","journal-title":"Stroke"},{"key":"986_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/STROKEAHA.112.674614","volume":"44","author":"JW van Dalen","year":"2013","unstructured":"van Dalen JW, Moll van Charante EP, Nederkoorn PJ, van Gool WA, Richard E. Poststroke apathy. Stroke. 2013;44:851\u201360.","journal-title":"Stroke"},{"key":"986_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12975-013-0293-y","volume":"5","author":"AL Harris","year":"2014","unstructured":"Harris AL, Elder J, Schiff ND, Victor JD, Goldfine AM. Post-stroke apathy and hypersomnia lead to worse outcomes from acute rehabilitation. Transl Stroke Res. 2014;5:292\u2013300.","journal-title":"Transl Stroke Res"},{"key":"986_CR9","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1038\/s41598-019-41042-2","volume":"12","author":"B Rohaut","year":"2019","unstructured":"Rohaut B, Doyle KW, Reynolds AS, Igwe K, Couch C, Matory A, et al. Deep structural brain lesions associated with consciousness impairment early after hemorrhagic stroke. Sci Rep. 2019;12:4174.","journal-title":"Sci Rep"},{"issue":"4","key":"986_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00002826-198908000-00003","volume":"12","author":"T Gualtieri","year":"1989","unstructured":"Gualtieri T, Chandler M, Coons TB, Brown LT. Amantadine: a new clinical profile for traumatic brain injury. Clin Neuropharmacol. 1989;12(4):258\u201370.","journal-title":"Clin Neuropharmacol"},{"issue":"Suppl","key":"986_CR11","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/0303-8467(92)90006-O","volume":"94","author":"JC Stoof","year":"1992","unstructured":"Stoof JC, Booij J, Drukarch B. Amantadine as N-methyl-d-aspartic acid receptor antagonist: new possibilities for therapeutic applications? Clin Neurol Neurosurg. 1992;94(Suppl):S4\u20136.","journal-title":"Clin Neurol Neurosurg"},{"key":"986_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.4088\/JCP.v67n0406","volume":"67","author":"JS Ballon","year":"2006","unstructured":"Ballon JS, Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry. 2006;67:554\u201366.","journal-title":"J Clin Psychiatry"},{"key":"986_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fnsyn.2018.00018","volume":"10","author":"A Gower","year":"2018","unstructured":"Gower A, Tiberi M. The Intersection of central dopamine system and stroke: potential avenues aiming at enhancement of motor recovery. Front Synaptic Neurosci. 2018;10:18.","journal-title":"Front Synaptic Neurosci"},{"key":"986_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1102609","volume":"366","author":"JT Giacino","year":"2012","unstructured":"Giacino JT, Whyte J, Bagiella E, Kalmar K, Childs N, Khademi A, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366:819\u201326.","journal-title":"N Engl J Med"},{"key":"986_CR15","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1080\/02699052.2018.1476733","volume":"32","author":"H Ghalaenovi","year":"2018","unstructured":"Ghalaenovi H, Fattahi A, Koohpayehzadeh J, et al. The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial. Brain Inj. 2018;32:1050\u20135.","journal-title":"Brain Inj"},{"key":"986_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00001199-200208000-00004","volume":"17","author":"JM Meythaler","year":"2002","unstructured":"Meythaler JM, Brunner RC, Johnson A, Novack TA. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil. 2002;17:300\u201313.","journal-title":"J Head Trauma Rehabil"},{"key":"986_CR17","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1161\/STROKEAHA.115.010860","volume":"46","author":"MB Poulsen","year":"2015","unstructured":"Poulsen MB, Damgaard B, Zerahn B, Overgaard K, Rasmussen RS. Modafinil may alleviate poststroke fatigue: a randomized, placebo-controlled, double-blinded trial. Stroke. 2015;46:3470\u20137.","journal-title":"Stroke"},{"issue":"2","key":"986_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.5152\/TJAR.2018.20280","volume":"46","author":"EF Ak\u00e7\u0131l","year":"2018","unstructured":"Ak\u00e7\u0131l EF, Dilmen \u00d6K, Vehid H, Tunal\u0131 Y. Can amantadine ameliorate neurocognitive functions after subarachnoid haemorrhage? A preliminary study. Turk J Anaesthesiol Reanim. 2018;46(2):100\u20137.","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"986_CR19","first-page":"553","volume":"17","author":"A Pokryszko-Dragan","year":"2008","unstructured":"Pokryszko-Dragan A, S\u0142otwi\u0144ski K, Budrewicz SP, Podemski R, Zagrajek M, Bili\u0144ska M. Attention level and event-related evoked potentials in patients with cerebrovascular disease treated with amantadine sulfate: a pilot study. Adv Clin Exp Med. 2008;17:553\u20138.","journal-title":"Adv Clin Exp Med"},{"key":"986_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00702-004-0112-4","volume":"111","author":"B Saniova","year":"2004","unstructured":"Saniova B, Drobny M, Kneslova L, Minarik M. The outcome of patients with severe head injuries treated with amantadine sulphate. J Neural Transm (Vienna). 2004;111:511\u20134.","journal-title":"J Neural Transm (Vienna)"},{"key":"986_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/0885066619841603","author":"ME Barra","year":"2019","unstructured":"Barra ME, Izzy S, Sarro-Schwartz A, Hirschberg RE, Mazwi N, Edlow BL. Stimulant therapy in acute traumatic brain injury: Prescribing patterns and adverse event rates at 2 level 1 trauma centers. J Intensive Care Med. 2019. https:\/\/doi.org\/10.1177\/0885066619841603(Epub ahead of print).","journal-title":"J Intensive Care Med"},{"key":"986_CR22","unstructured":"Amantadine [package insert]. Chadds Ford: Endo Pharmaceuticals Inc.; 2009."},{"key":"986_CR23","unstructured":"Modafinil [package insert]. North Wales: Teva Pharmaceuticals USA, Inc.; 2015."},{"key":"986_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jcrc.2016.09.006","volume":"37","author":"DJ Gagnon","year":"2017","unstructured":"Gagnon DJ, Fontaine GV, Smith KE, Riker RR, Miller RR 3rd, Lerwick PA, et al. Valproate for agitation in critically ill patients: a retrospective study. J Crit Care. 2017;37:119\u201325.","journal-title":"J Crit Care"},{"key":"986_CR25","unstructured":"ICH Harmonised Tripartite Guideline. Guideline For Good Clinical Practice E6(R1). https:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6\/E6_R1_Guideline.pdf. Accessed 20 June 2019."},{"key":"986_CR26","first-page":"CD006187","volume":"10","author":"P Langhorne","year":"2018","unstructured":"Langhorne P, Collier JM, Bate PJ, Thuy MN, Bernhardt J. Very early versus delayed mobilisation after stroke. Cochrane Database Syst Rev. 2018;10:CD006187.","journal-title":"Cochrane Database Syst Rev"},{"key":"986_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0140-6736(15)60690-0","volume":"386","author":"AVERT Trial Collaboration group","year":"2015","unstructured":"AVERT Trial Collaboration group. Efficacy and safety of very early mobilisation within 24\u00a0h of stroke onset (AVERT): a randomised controlled trial. Lancet. 2015;386:46\u201355.","journal-title":"Lancet"},{"key":"986_CR28","doi-asserted-by":"crossref","unstructured":"Lehnerer SM, Scheibe F, Buchert R, Kliesch S, Meisel A. Awakening with amantadine from a persistent vegetative state after subarachnoid haemorrhage. BMJ Case Rep. 2017; pii: bcr-2017-220305.","DOI":"10.1136\/bcr-2017-220305"},{"issue":"3","key":"986_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0014-2999(85)90564-3","volume":"110","author":"G Gianutsos","year":"1985","unstructured":"Gianutsos G, Chute S, Dunn JP. Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine. Eur J Pharmacol. 1985;110(3):357\u201361.","journal-title":"Eur J Pharmacol"},{"key":"986_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.seizure.2017.06.022","volume":"50","author":"AL Turner","year":"2017","unstructured":"Turner AL, Perry MS. Outside the box: medications worth considering when traditional antiepileptic drugs have failed. Seizure. 2017;50:173\u201385.","journal-title":"Seizure"},{"key":"986_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1164\/rccm.201101-0065OC","volume":"184","author":"MM van Eijk","year":"2011","unstructured":"van Eijk MM, van den Boogaard M, van Marum RJ, Benner P, Eikelenboom P, Honing ML, et al. Routine use of the confusion assessment method for the intensive care unit: a multicenter study. Am J Respir Crit Care Med. 2011;184:340\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"986_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/CCM.0000000000004031","volume":"48","author":"ME Reznik","year":"2020","unstructured":"Reznik ME, Drake J, Margolis SA, Moody S, Murray K, Costa S, et al. Deconstructing poststroke delirium in a prospective cohort of patients with intracerebral hemorrhage. Crit Care Med. 2020;48:111\u20138.","journal-title":"Crit Care Med"},{"key":"986_CR33","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/CCM.0000000000003399","volume":"46","author":"RR Riker","year":"2018","unstructured":"Riker RR, Fraser GL. In the middle of difficulty lies opportunity-Albert Einstein. Crit Care Med. 2018;46:1881\u20132.","journal-title":"Crit Care Med"},{"key":"986_CR34","doi-asserted-by":"publisher","first-page":"964578","DOI":"10.1155\/2014\/964578","volume":"2014","author":"AA Herrold","year":"2014","unstructured":"Herrold AA, Pape TL, Guernon A, Mallinson T, Collins E, Jordan N. Prescribing multiple neurostimulants during rehabilitation for severe brain injury. Sci World J. 2014;2014:964578.","journal-title":"Sci World J"},{"key":"986_CR35","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S1474-4422(19)30162-0","volume":"18","author":"CM Stinear","year":"2019","unstructured":"Stinear CM. Dopamine for motor recovery after stroke: where to from here? Lancet Neurol. 2019;18:514\u20135.","journal-title":"Lancet Neurol"},{"key":"986_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000232927","volume":"62","author":"A Brioschi","year":"2009","unstructured":"Brioschi A, Gramigna S, Werth E, Staub F, Ruffieux C, Bassetti C, et al. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol. 2009;62:243\u20139.","journal-title":"Eur Neurol"},{"key":"986_CR37","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1001\/jamaneurol.2018.2338","volume":"75","author":"LB Goldstein","year":"2018","unstructured":"Goldstein LB, Lennihan L, Rabadi MJ, Good DC, Reding MJ, Dromerick AW, et al. Effect of dextroamphetamine on poststroke motor recovery: a randomized clinical trial. JAMA Neurol. 2018;75:1494\u2013501.","journal-title":"JAMA Neurol"},{"issue":"1","key":"986_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000329275","volume":"66","author":"A Delbari","year":"2011","unstructured":"Delbari A, Salman-Roghani R, Lokk J. Effect of methylphenidate and\/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial. Eur Neurol. 2011;66(1):7\u201313.","journal-title":"Eur Neurol"},{"key":"986_CR39","doi-asserted-by":"crossref","unstructured":"Kovacic NL, Gagnon DJ, Riker RR, Wen S, Fraser GL. An analysis of psychoactive medications initiated in the ICU but continued beyond discharge: a pilot study of stewardship. J Pharm Pract. 2019; 897190019830518.","DOI":"10.1177\/0897190019830518"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-00986-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-020-00986-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-00986-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:40:34Z","timestamp":1744177234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-020-00986-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["986"],"URL":"https:\/\/doi.org\/10.1007\/s12028-020-00986-4","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"20 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We adhered to ethical guidelines. The Institutional Review Board at Maine Medical Center reviewed this study design and determined it to represent exempt research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}